Cargando…
Potential usefulness of apolipoprotein A2 isoforms for screening and risk stratification of pancreatic cancer
Given the low incidence of pancreatic cancer in the general population, screening of pancreatic cancer in the general population using invasive modalities is not feasible. Combination of invasive screening with noninvasive biomarkers for pancreatic cancer and its precancerous lesions has the potenti...
Autores principales: | Honda, Kazufumi, Srivastava, Sudhir |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Future Medicine Ltd
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5493967/ https://www.ncbi.nlm.nih.gov/pubmed/27673558 http://dx.doi.org/10.2217/bmm-2016-0209 |
Ejemplares similares
-
Risk stratification of pancreatic cancer by a blood test for apolipoprotein A2-isoforms
por: Honda, Kazufumi
Publicado: (2022) -
Prospective Study Using Plasma Apolipoprotein A2-Isoforms to Screen for High-Risk Status of Pancreatic Cancer
por: Sato, Yu, et al.
Publicado: (2020) -
Plasma biomarker for detection of early stage pancreatic cancer and risk factors for pancreatic malignancy using antibodies for apolipoprotein-AII isoforms
por: Honda, Kazufumi, et al.
Publicado: (2015) -
Apolipoprotein A2 Isoforms in Relation to the Risk of Myocardial Infarction: A Nested Case-Control Analysis in the JPHC Study
por: Kihara, Tomomi, et al.
Publicado: (2021) -
Apolipoprotein A2 Isoforms: New Insight into the Risk of Myocardial Infarction
por: Hisamatsu, Takashi
Publicado: (2021)